Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-21-134623

10% owner bought 1,000,000 shares at $20.00 ($20,000,000)

  • 10% owner acquired 954,420 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Redmile Group, LLC · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-02 Conversion : show line 1 in the form +954,420 954,420 I
2021-11-02 Purchase : show line 2 in the form +1,000,000 $20.00 $20,000,000 1,954,420 I
Open-market purchases · 1,000,000 sh · avg $20.00 · $20,000,000

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2021-11-02 Conversion : show line 3 in the form Series B Convertible Preferred Stock −954,420 954,420 0 I
Loading xslF345X03/tm2131859-1_4seq1.xml…